Introduction Early recurrence after hepatectomy remains a major obstacle to durable disease control in hepatocellular carcinoma (HCC). This study developed and externally validated a prediction model based on preoperative MRI features and clinical laboratory factors for early recurrence after hepatectomy for HCC, defin...
Quan-You Miao, Chao-Feng Yang, Ling Yang et al.· Frontiers in Oncology· 0 citations
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by renal phosphate wasting, resulting in hypophosphatemia and altered bone turnover. It is most frequently caused by phosphaturic mesenchymal tumors (PMTs), a rare and distinct group of neoplasms. Patients with TIO exhibit clinical feature...
Wu-Xiao Cui, Ting Liu, Shu-Qian Mo et al.· Frontiers in Surgery· 0 citations
As a prevalent malignancy, liver cancer ranks as the third most common cause of cancer mortality globally. Within the tumor microenvironment, tumor-associated macrophages (TAMs) exhibit contrasting functional phenotypes: the anti-tumor M1 type and the pro-tumor M2 type. Reprogramming TAMs from the M2 to the M1 phenotyp...
Pei-Pei He, Zheng-Ju Hou, Han-Mei Li et al.· PLoS ONE· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.